Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug;140(2):447-453.e3.
doi: 10.1016/j.jaci.2016.12.980. Epub 2017 Feb 20.

Substance P activates Mas-related G protein-coupled receptors to induce itch

Affiliations

Substance P activates Mas-related G protein-coupled receptors to induce itch

Ehsan Azimi et al. J Allergy Clin Immunol. 2017 Aug.

Abstract

Background: Substance P (SP) is linked to itch and inflammation through activation of receptors on mast cells and sensory neurons. There is increasing evidence that SP functions through Mas-related G protein-coupled receptors (Mrgprs) in addition to its conventional receptor, neurokinin-1.

Objective: Because Mrgprs mediate some aspects of inflammation that had been considered mediated by neurokinin-1 receptor (NK-1R), we sought to determine whether itch induced by SP can also be mediated by Mrgprs.

Methods: Genetic and pharmacologic approaches were used to evaluate the contribution of Mrgprs to SP-induced scratching behavior and activation of cultured dorsal root ganglion neurons from mice.

Results: SP-induced scratching behavior and activation of cultured dorsal root ganglion neurons was dependent on Mrgprs rather than NK-1R.

Conclusion: We deduce that SP activates MrgprA1 on sensory neurons rather than NK-1R to induce itch.

Keywords: Mas-related G protein–coupled receptors; Substance P; calcium imaging; dorsal root ganglion neurons; knockout mice; receptor antagonist.

PubMed Disclaimer

Conflict of interest statement

Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.

Figures

FIG 1
FIG 1
Mrgprs mediate SP-induced itch. A, SP-induced itch (500 µmol/L administered intradermally [i.d.]) is significantly decreased in Mrgpr cluster Δ−/− mice. B, Effects of treatment with the NK-1R antagonist L733060 (500 µmol/L administered intradermally) or the dual NK-1R/Mrgpr antagonist QWF (500 µmol/L administered intradermally) on scratching behavior caused by SP (500 µmol/L administered intradermally). Data are expressed as means ± SEMs. The unpaired Student t test (n = 7 mice per group in Fig 1, A) and 1-way ANOVA followed by the Tukey test (n = 6 mice per group in Fig 1, B) were used. Significant differences from wild-type mice (†P < .05), baseline (#P < .05), SP plus vehicle (*P < .05), or SP plus L733060 ($$P < .01) are indicated.
FIG 2
FIG 2
Effect of QWF on capsaicin-induced Ca2+ flux and thermal hyperalgesia. A, QWF (1 µmol/L) does not affect Ca2+ flux induced by capsaicin (1 µmol/L) and KCl (40 mmol/L) in cultured wild-type DRG neurons. B, QWF (1 µmol/L, intraplantar) has no effect on capsaicin-induced thermal hyperalgesia in wild-type mice. Data are expressed as means ± SEMs. One-way ANOVA followed by the Tukey test (n = 6 mice per group). Statistical differences from vehicle are indicated as follows: ###P < .001. Total number of cells analyzed in Fig 2, A, was 267.
FIG 3
FIG 3
SP activates NK-1R−/− nociceptors. A, SP (10–1000 nmol/L) induces Ca2+ flux in wild-type (gray) and NK-1R−/− (black) cultured DRG neurons. B, Percentage of SP-responding cells from wild-type or NK-1R−/− mice. C, Maximal Ca2+ flux in DRG neurons from wild-type (gray) and NK-1R−/− (black) mice. D, Size of SP-responsive cells from NK-1R−/− mice. Inset, Venn diagram showing overlapping populations of KCl-positive, capsaicin-positive, and SP-responsive neurons. E, Ca2+ flux induced by SP (1 µmol/L), capsaicin (1 µmol/L), and KCl (40 mmol/L) in DRG neurons from wild-type (gray) and TRPV1-Cre+/−DTA+/−(red) mice. The unpaired Student t test was used. Significant differences from NK-1R−/− were indicated as follows: **P < .01 and ***P < .001. Total number of cells analyzed was as follows: Fig 3, A–C, 328 (wild-type) and 1463 (NK-1R−/−); Fig 3, D, 1463; Fig 3, D, inset, 314; and Fig 3, E, 787 (wild-type) and 246 (TRPV1-Cre+/−DTA+/−).
FIG 4
FIG 4
Effect of QWF on SP-induced Ca2+ flux in cultured DRG neurons from NK-1R−/− mice. A, QWF (1 µmol/L) blocks SP-induced (300 nmol/L) Ca2+ flux in DRG neurons from NK-1R−/− mice. Cells blocked by QWF also respond to allyl isothiocyanate (1 µmol/L), capsaicin (1 µmol/L), and KCl (40 mmol/L). B, Amplitude of SP-induced Ca2+ flux in NK-1R−/− neurons before and after treatment with QWF (1 µmol/L). Data are expressed as means ± SEMs. The paired Student t test was used. Statistical difference from SP is indicated as follows: ***P < .001. Total number of cells analyzed was as follows: Fig 4, A, 314; Fig 4, B, 492.

References

    1. Duval A, Dubertret L. Aprepitant as an antipruritic agent? N Engl J Med. 2009;361:1415–6. - PubMed
    1. Stander S, Siepmann D, Herrgott I, Sunderkotter C, Luger TA. Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLoS One. 2010;5:e10968. - PMC - PubMed
    1. Santini D, Vincenzi B, Guida FM, Imperatori M, Schiavon G, Venditti O, et al. Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study. Lancet Oncol. 2012;13:1020–4. - PubMed
    1. Wallengren J. Topical aprepitant in clinical and experimental pruritus. Arch Dermatol. 2012;148:957–9. - PubMed
    1. Wallengren J, Edvinsson L. Topical non-peptide antagonists of sensory neurotransmitters substance P and CGRP do not modify patch test and prick test reactions: a vehicle-controlled, double-blind pilot study. Arch Dermatol Res. 2014;306:505–9. - PubMed